Summary
- Current Price
- As of today, DRUG price is $71.46, down -0.36% on
- Current Price All-Time High
- DRUG price is currently -42.25% below its historical high of $123.75 set on
- Market Cap
- DRUG current market cap is $709M, up +183.67% over the past 365 days
- PE Ratio
- DRUG PE ratio is unknown
- Revenue
- DRUG current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for DRUG is on
Profile
| Metric | Value |
|---|---|
| Full Name | Bright Minds Biosciences Inc. |
| Ticker | NASDAQ: DRUG |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | brightmindsbio.com |
| Employees | - |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $71.46 | |
| Price, 1D Change | -0.36% | |
| $709M | ||
| - | ||
| - | ||
| 1.20 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.27 | ||
| EPS, 1Y Change | -166.21% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:5 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.27 | ||
| EPS Estimate | N/A | -$6.65 |
| EPS Est. Change | N/A | -422.92% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $71.46 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.30 | -$1.27 | +44.77% | |
| -$6.65 | N/A | -422.92% | |
| -$9.07 | N/A | -613.53% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | N/A | - | |
| $39.21M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $71.46 | |
| $60.27 | ||
| SMA 200 vs Price | -15.66% | |
| $78.17 | ||
| SMA 50 vs Price | +9.39% | |
| 1.20 | ||
| $5.02 | ||
| 43.48 | ||
| 47.87% | ||
| 74.19% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.27 | ||
| -$55.00K | ||
| - | ||
| -$9.94M | ||
| - | ||
| -$8.75M | ||
| - | ||
| -$9.89M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 36.10 | ||
| 36.10 | ||
| - | ||
| - | ||
| 249.07 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 10.89 | ||
| -47.04 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $58.97M | ||
| $59.59M | ||
| $60.67M | ||
| $60.59M | ||
| $1.71M | ||
| $1.68M | ||
| $90.40K | ||
| $60.80K | ||
| $0.00 |
Expenses
| Metric | Date | Value |
|---|---|---|
| $8.75M | ||
| $9.89M | ||
| $55.00K | ||
| $0.00 | ||
| $55.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$6.22M | ||
| $0.00 | ||
| $61.19M | ||
| $0.00 | ||
| -$6.22M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| BTIG | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| BTIG | → | |
| BTIG | → | |
| Chardan Capital | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| BTIG | ||
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with DRUG
FAQ
What is the ticker symbol for Bright Minds Biosciences Inc.?
The ticker symbol for Bright Minds Biosciences Inc. is NASDAQ:DRUG
Does Bright Minds Biosciences Inc. pay dividends?
No, Bright Minds Biosciences Inc. does not pay dividends
What sector is Bright Minds Biosciences Inc. in?
Bright Minds Biosciences Inc. is in the Healthcare sector
What industry is Bright Minds Biosciences Inc. in?
Bright Minds Biosciences Inc. is in the Biotechnology industry
What country is Bright Minds Biosciences Inc. based in?
Bright Minds Biosciences Inc. is headquartered in United States
When did Bright Minds Biosciences Inc. go public?
Bright Minds Biosciences Inc. initial public offering (IPO) was on March 22, 2021
Is Bright Minds Biosciences Inc. in the S&P 500?
No, Bright Minds Biosciences Inc. is not included in the S&P 500 index
Is Bright Minds Biosciences Inc. in the NASDAQ 100?
No, Bright Minds Biosciences Inc. is not included in the NASDAQ 100 index
Is Bright Minds Biosciences Inc. in the Dow Jones?
No, Bright Minds Biosciences Inc. is not included in the Dow Jones index
When was Bright Minds Biosciences Inc. last earnings report?
Bright Minds Biosciences Inc.'s most recent earnings report was on February 19, 2026
When does Bright Minds Biosciences Inc. report earnings?
The next expected earnings date for Bright Minds Biosciences Inc. is May 15, 2026
Data Sources & References
- DRUG Official Website brightmindsbio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1827401/000106299326000881/0001062993-26-000881-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1827401/000143774925038729/0001437749-25-038729-index.htm
- DRUG Profile on Yahoo Finance finance.yahoo.com/quote/DRUG
- DRUG Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/drug